What the USPTO’s New 30-Day Director Review Deadline for Decisions Instituting Trial Means for PTAB Petitioners and Patent Owners
Key Takeaway: In a precedential decision in Light & Wonder, Inc. v. Evolution Malta Ltd., U.S. Patent and Trademark Office Director Squires extended the deadline for requesting Director Review of...
PTAB Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
Knobbe Martens, Dozens of Partners Receive Top Rankings in IP Law in Legal 500 USA Guide
IRVINE, Calif., June 11, 2026 – Knobbe Martens, a leading intellectual property law firm, is proud to share that the firm and three dozen lawyers received national and regional recognition...
Jarom Kesler Comments on USPTO Ex Parte Reexamination Denial Trends in Law360
In the Law360 article “USPTO Clamping Down Reexam Bids After IPR Denials,” Knobbe Martens partner Jarom Kesler shared how a recent ruling from the U.S. Patent and Trademark Office (USPTO)...
Sheila Swaroop Named “Patent Lawyer of the Year” at 2026 IFLR Women in Business Law Awards
IRVINE, Calif., May 29, 2026 – Knobbe Martens is pleased to share that Sheila Swaroop, Chair of Knobbe Martens’ Litigation practice, was named the “North America Patent Lawyer of the...
Dozens of Knobbe Martens Partners Recognized in 2026 IAM Patent 1000 Guide
IRVINE, Calif., May 28, 2026 – Knobbe Martens, a leading intellectual property law firm, and its partners were once again recognized for excellence across patent law in the 2026 edition...
Three Knobbe Martens Partners Named Among Top IP Lawyers in California by Daily Journal
Sheila Swaroop, Brian Horne and Joseph Re recognized for strength in intellectual property litigation IRVINE, Calif., May 20, 2026 – Reflecting the firm’s strengths in high-stakes litigation, Knobbe Martens is...
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board
Key Takeaway: In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc., USPTO Director Squires denied IPR institution and reinforced the policy framework for discretionary denial at the...
PTAB Update | April 2026
USPTO Introduces Pre-Order Papers for Patent Owners in Ex Parte Reexaminations Jarom D. Kesler & Joshua M. Martineau With the decline of inter partes review (IPR) proceedings and the significant...
Tom Cowan Discusses IP Issues Relevant to “Dual-Use” Aerospace Technologies on The Space Hour Podcast
In a recent episode of The Space Hour podcast, Knobbe Martens partner Tom Cowan offered insights on the unique intellectual property (IP) challenges facing “dual-use” aerospace companies – those technology...
Standing Still? Only if Injury-In-Fact Is Tied to the Claims at Issue
IRONSOURCE LTD. v. DIGITAL TURBINE, INC. Before Moore, Lourie, and Reyna. Appeal from the Patent Trial and Appeal Board. Summary: An appellant seeking to establish Article III standing based on...
USPTO Introduces Pre-Order Papers for Patent Owners in Ex Parte Reexaminations
Key Takeaway: With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is allowing...
One Battle After Another: Broad Institute Wins at PTAB in CRISPR Dispute
Key Takeaways: Interference proceedings, though increasingly rare, are heavily evidence-based and determine which party is the first inventor when two or more applicants claim the same patentable invention. Sometimes, an...
Jeremiah Helm and Sean Murray Discuss Federal Circuit Decision on Patent Claim Language in Law360 Article
Knobbe Martens partners Jeremiah Helm and Sean Murray explored the Federal Circuit’s opinion on patent claim construction in Netflix Inc. v. DivX LLC in their latest Law360 column on the...
PTAB to Rehear Ex Parte Baurin: Revisiting the Interplay of Obviousness-Type Double Patenting and Patent Term Adjustment After Cellect and Allergan
Key Takeaway: The PTO Director’s sua sponte rehearing of Ex parte Baurin raises questions regarding the scope of Allergan v. MSN, Examiners’ role in obviousness-type double patenting rejections, and the...
USPTO Director to Consider U.S. Manufacturing and Small Business Status When Instituting or Denying IPR and PGR Petitions
Key Takeaways Effective immediately, the USPTO will consider whether a patent challenger’s accused products or a patent owner’s products are manufactured in the United States as additional factors in the...
Sheila Swaroop Comments on USPTO Memo on U.S. Manufacturing Factors in AIA Reviews
In the Law360 article “Manufacturing Factor Adds More New Twists to AIA Cases,” Knobbe Martens partner Sheila Swaroop weighed in on the U.S. Patent & Trademark Office’s latest memo regarding...
Presented by Netflix—Grammar Police: An Exercise in Claim Construction
NETFLIX, INC. V. DIVX, LLC Before Moore, Dyk, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary: Common principles of English grammar may be used to identify the...
Challenged Director-To-PTAB Instructions Did Not Require Notice-And-Comment Rulemaking
APPLE INC. v. SQUIRES Before Lourie, Taranto, and Chen. Appeal from the United States District Court for the Northern District of California. Summary: Challenged instructions that the PTO’s Director gave...
PTAB Update | January 2026
Available Now: Federal Circuit Year in Review Report Knobbe Martens’ 2025 Federal Circuit Year in Review report, covering over 50 of the most noteworthy patent-related Federal Circuit decisions issued last...
Knobbe Martens Partners Outline Major USPTO Policy Shifts in Law360 Article
In a recent Law360 article, Knobbe Martens partners Rosaleen Chou, Ted Cannon, and Philip Nelson highlight significant policy developments at the U.S. Patent and Trademark Office (USPTO) expected to shape...
